Health

  • December 22, 2025

    Hochul Signs AG James' Bill To Expand Consumer Law

    New York Gov. Kathy Hochul has signed into law New York Attorney General Letitia James' legislation to expand the state's ban on deceptive business practices to also protect against unfair and abusive practices, in the first updates to the state's primary consumer protection law in 45 years.

  • December 22, 2025

    DOJ, SEC Charge 6 In $41M Insider Trading Scheme

    Federal prosecutors in New Jersey have charged six people in connection with what the government is alleging are securities fraud schemes that led to at least $41 million in illicit profits from insider trading, as well as gains from manipulating the stock prices of biopharmaceutical companies.

  • December 22, 2025

    Supreme Court Halts Pittsburgh Post-Gazette Union Order

    The U.S. Supreme Court stayed a Third Circuit order Monday that had required the Pittsburgh Post-Gazette to bargain in good faith with its newsroom workers' union and rescind changes to their healthcare and working conditions, pressing pause on an order that ended a three-year strike at the paper.

  • December 22, 2025

    6th Circ. Vacates Pharma Salesman's $6.8M Restitution Order

    The Sixth Circuit vacated a nearly $7 million restitution order against a pharmaceutical salesman convicted of healthcare fraud, finding an Ohio federal court erred in calculating that amount and apportioning liability.

  • December 22, 2025

    Ed Dept. Ordered To Restore $1B In Mental Health Grants

    The U.S. Department of Education will not be allowed to cut more than $1 billion in mental health grants for schools after a Washington federal judge ruled that the agency acted illegally by citing new, undisclosed Trump administration priorities as a basis for slashing the funding.

  • December 22, 2025

    New Class Action Claims CIBC, RBC Rigged Quantum Shares

    A Quantum Biopharma investor has filed a proposed class action against several major Canadian banks, accusing them of running a spoofing scheme for years that artificially drove down Quantum's stock price — flooding exchanges with fake sell orders to mislead the market and buy shares at deflated prices, costing ordinary shareholders millions.

  • December 19, 2025

    J&J Hit With $66M Verdict In Minnesota Mom's Asbestos Case

    A Minnesota jury Friday awarded a mother of three $65.5 million following a 13-day trial in her lawsuit that claimed Johnson & Johnson's talc products exposed her to asbestos and contributed to cancer in her abdominal lining, the mother's attorneys announced.

  • December 19, 2025

    Feds Fight 'Do-Over' Of Tort Atty's Attempted-Extortion Rap

    Federal prosecutors are urging the Fourth Circuit not to give "a do-over" to a medical malpractice attorney who was convicted of attempting to extort the University of Maryland Medical System out of $25 million and who says his self-representation at trial was not competent.

  • December 19, 2025

    Trump's Cannabis Order: The Impact On Hemp And Research

    President Donald Trump's executive order Thursday reignited an administrative process to reclassify marijuana as a less restricted drug, but its provisions touching on cannabis research and hemp-derived CBD are less obvious.

  • December 19, 2025

    Health Co. CEO Gets 15 Years In $1.4B Fraud Scheme

    A Florida federal judge sentenced a software company CEO to 15 years in prison Friday for participating in a scheme to coordinate illegal medical kickbacks through an internet platform, an operation that resulted in $1.4 billion worth of false billings to Medicare and other insurers for unnecessary medical products.

  • December 19, 2025

    Michigan's 5 Biggest Court Rulings Of 2025

    Michigan courts had a memorable year in 2025, issuing rulings that extended protections against automatic life sentences to young adults, struck down abortion restrictions and pulled the plug on criminal cases related to President Donald Trump's so-called fake elector plot.

  • December 19, 2025

    AstraZeneca Unit Ducks Patent Fraud, Not Sham Suit Claims

    A Massachusetts federal judge spared AstraZeneca unit Alexion on Friday from half of a nonprofit insurer's proposed class action, finding the plaintiff too far removed from anticompetitive patent fraud that allegedly propped up blood disorder treatment Soliris, while preserving accusations that Alexion brought sham infringement allegations against would-be rivals.

  • December 19, 2025

    Squires Issues 21 More Patent Review Denials

    U.S. Patent and Trademark Office Director John Squires has denied 21 requests for America Invents Act patent reviews, while not agreeing to institute any new proceedings.

  • December 19, 2025

    Medical, School Groups Seek Order Halting $100K Visa Fee

    A medical practice in rural North Carolina and other employers asked a federal judge Friday to block enforcement of the Trump administration's $100,000 fee on H-1B visas, arguing the "massive" fee hike will inflict irreparable harm on their communities.

  • December 19, 2025

    Florida Supreme Court To Review Pot Legalization Effort

    The Florida Supreme Court has agreed to weigh whether a new proposal to legalize retail marijuana via ballot initiative complies with the state's constitution.

  • December 19, 2025

    BigLaw And Boutiques Both Shine In 2025's Top 10 Deals

    A tight circle of elite law firms guided the way as megadeals roared back with force in 2025, while a small group of specialist and international firms also made their mark across global transactions spanning infrastructure, gaming, pharmaceuticals, artificial intelligence and energy.

  • December 19, 2025

    Taxation With Representation: Baker Botts, Morgan Lewis

    In this week's Taxation With Representation, Trump Media and Technology Group merges with fusion power company TAE Technologies, pharmaceutical company Cencora boosts its stake in cancer care company OneOncology, and Phoenix Financial partners with private equity giant Blackstone to plug billions into various credit strategies.

  • December 19, 2025

    Hospital Knocks Discharge Claim From EEOC Sex Bias Suit

    An Arkansas federal judge agreed to cut the constructive discharge allegation from a U.S. Equal Employment Opportunity Commission lawsuit alleging two doctors at an Arkansas hospital refused to let a male medical assistant help with childbirth, noting that the worker assisted with other deliveries.

  • December 19, 2025

    Trump Admin Appeals Harvard Win In $2B Fund Freeze Case

    The Trump administration will ask the First Circuit to overturn a federal judge's ruling that prevented the government from withholding $2.2 billion in federal grants from Harvard University over concerns about antisemitism on campus.

  • December 19, 2025

    The 6 Biggest Rulings By Massachusetts' Top Court In 2025

    Massachusetts' top court rejected a novel double jeopardy claim in a headline-grabbing murder case, revived claims against Harvard over a "ghoulish" scheme, and said a Snapchat Bitmoji could show police bias, among other significant rulings this year.

  • December 19, 2025

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen the designer of an 88-facet diamond bring a copyright claim against a luxury watch retailer, collapsed firm Axiom Ince bring legal action against the solicitors' watchdog, and the Post Office hit with compensation claims from two former branch managers over their wrongful convictions during the Horizon information technology scandal.

  • December 19, 2025

    BioMarin Inks $4.8B Amicus Buy As Patent Litigation Resolved

    BioMarin Pharmaceutical Inc. has agreed to acquire Amicus Therapeutics for $4.8 billion, in a deal bolstered by Amicus' settlement of patent litigation that secures U.S. exclusivity for its Galafold drug until 2037, the companies said Friday.

  • December 18, 2025

    The Biggest Rulings From A Busy Year At The 1st Circ.

    The nation's smallest federal appellate panel punched above its weight in 2025, grappling with numerous suits against the Trump administration, high-profile criminal appeals, a $34 million legal fee bid and a hotly contested kickback law.

  • December 18, 2025

    Trump Order Rallies Cannabis Industry, Advocates Want More

    The executive order signed by President Donald Trump on Thursday, marking the most substantial shift in federal cannabis policy in over half a century, is expected to have favorable ramifications for the marijuana industry even as it falls short of decriminalizing the drug or resolving the many tensions between federal and state law.

  • December 18, 2025

    Split 6th Circ. Blocks Michigan's Ban On Conversion Therapy

    A split Sixth Circuit panel ordered an injunction on Michigan's conversion therapy ban, ruling the law likely places an unconstitutional restriction on the First Amendment rights of a Catholic charitable organization and a therapist whose faith-based psychotherapy practices fall under the ban.

Expert Analysis

  • Opinion

    Despite Deputy AG Remarks, DOJ Can't Sideline DC Bar

    Author Photo

    Deputy Attorney General Todd Blanche’s recent suggestion that the D.C. Bar would be prevented from reviewing misconduct complaints about U.S. Department of Justice attorneys runs contrary to federal statutes, local rules and decades of case law, and sends the troubling message that federal prosecutors are subject to different rules, say attorneys at HWG.

  • Unique Aspects Of Texas' Approach To AI Regulation

    Author Photo

    The Texas Responsible AI Governance Act — which will soon be the sole comprehensive artificial intelligence law in the U.S. — pulls threads from EU and Colorado laws but introduces more targeted rules with fewer obligations on commercial entities, say attorneys at MVA Law.

  • 3 Takeaways From FDA Cell And Gene Therapy Draft Guidance

    Author Photo

    The U.S. Food and Drug Administration recently published draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, reflecting an agency that is increasingly comfortable with flexible, science-driven approaches that extend beyond clinical trial models, say attorneys at MoFo.

  • Rule Amendments Pave Path For A Privilege Claim 'Offensive'

    Author Photo

    Litigators should consider leveraging forthcoming amendments to the Federal Rules of Civil Procedure, which will require early negotiations of privilege-related discovery claims, by taking an offensive posture toward privilege logs at the outset of discovery, says David Ben-Meir at Ben-Meir Law.

  • IP Ownership Risk Grows In Booming Cancer Drug Market

    Author Photo

    The ownership of intellectual property has become strategically decisive in deals involving valuable cancer therapeutics known as ADCs, as highlighted by the recent Takeda-Innovent deal, with the commercial value of a license resting on the integrity and defensibility of the underlying technology, say attorneys at Loeb & Loeb.

  • Series

    My Miniature Livestock Farm Makes Me A Better Lawyer

    Author Photo

    Raising miniature livestock on my farm, where I am fully present with the animals, is an almost meditative time that allows me to return to work invigorated, ready to juggle numerous responsibilities and motivated to tackle hard issues in new ways, says Ted Kobus at BakerHostetler.

  • Surveying The Healthcare Policy Landscape Post-Shutdown

    Author Photo

    With last week's agreement to reopen the federal government, at least through the end of January, key healthcare legislation that has been in limbo since a December 2024 spending bill fell apart may recapture the attention of Congress, say attorneys at Faegre Drinker.

  • FDA Biosimilar Guidance Should Ease Biologics Development

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration, indicating that the agency may no longer routinely require comparative efficacy studies when other evidence provides sufficient assurance of biosimilarity, underscores the FDA's trust in analytical technology as a driver of biologics access, say attorneys at Hogan Lovells.

  • Litigation Funding Could Create Ethics Issues For Attorneys

    Author Photo

    A litigation investor’s recent complaint claiming a New York mass torts lawyer effectively ran a Ponzi scheme illustrates how litigation funding arrangements can subject attorneys to legal ethics dilemmas and potential liability, so engagement letters must have very clear terms, says Matthew Feinberg at Goldberg Segalla.

  • E-Discovery Quarterly: Recent Rulings On Dynamic Databases

    Author Photo

    Several recent federal court decisions illustrate how parties continue to grapple with the discovery of data in dynamic databases, so counsel involved in these disputes must consider how structured data should be produced consistent with the requirements of the Federal Rules of Civil Procedure, say attorneys at Sidley.

  • Prison Body Cams Raise Health Privacy Compliance Issues

    Author Photo

    The increasing use of prison staff body cameras to enhance transparency and safety presents correctional healthcare partners with new risk management questions where they must carefully reconcile the benefits of surveillance with the imperative to protect patient privacy, say attorneys at Gordon Rees.

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

  • Series

    Law School's Missed Lessons: Networking 101

    Author Photo

    Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • How Cos. Can Prep For Tightened Calif. Data Breach Notices

    Author Photo

    Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.